Warning for women having both breasts removed

Share this article
Have your say

Nearly three-quarters of women who have both breasts removed after a cancer diagnosis may be wrong to take the drastic step, a study has suggested.

Researchers who studied 1,447 women treated for breast cancer found that eight per cent of them had undergone a double mastectomy.

But 70 per cent of these women did not meet the medically approved criteria for losing both breasts - a family history of breast or ovarian cancer, or BRCA 1 or BRCA 2 gene mutations.

They had a very low risk of developing cancer in the healthy breast, the US scientists said.

Study leader Dr Sarah Hawley, from the University of Michigan, said: “Women appear to be using worry over cancer recurrence to choose contralateral prophylactic mastectomy.

“This does not make sense, because having a non-affected breast removed will not reduce the risk of recurrence in the affected breast.

“For women who do not have a strong family history or a genetic finding, we would argue it’s probably not appropriate to get the unaffected breast removed.”

The research, published in the journal JAMA Surgery, also found that 18 per cent of the women studied had considered a double mastectomy.

Women with a risky family history and BRCA mutations make up around 10 per cent of all those diagnosed with breast cancer.

They are considered to be at high risk of a new cancer developing in the unaffected breast. Without these indications, women who develop a tumour in one breast are very unlikely to acquire a second cancer in the other.

Many of the women in the study who elected to have a double mastectomy were candidates for breast-conserving surgery to remove lumps, the researchers said. Overall, about three-quarters of the patients reported being very worried about their cancer.

Those who chose to have both breasts removed were significantly more likely to be concerned.

A double mastectomy is a major operation that can be associated with complications and difficult recovery, the authors pointed out.

Most of the participants who had the procedure underwent breast reconstruction as well.

The study found that women with higher education levels and who had been given a magnetic resonance imaging (MRI) scan before surgery were more likely to choose a double mastectomy.

The new research coincides with former Dancing With The Stars host Samantha Harris making public her decision to have a double mastectomy following a diagnosis of breast cancer.

She was praised by Baroness Delyth Morgan, chief executive of the Breast Cancer Campaign charity, who said: “Samantha’s openness in sharing her experience serves as a stark reminder of the impact of a breast cancer diagnosis. It also raises awareness of the fact that breast cancer can occur at any age, although 80% of the 50,000 cases diagnosed in the UK each year occur in women over 50.

“Being breast aware can be crucial to early diagnosis, increasing chances of survival. It is important women report any unusual changes to their GP and consider attending routine breast screening when invited.”

Ms Harris discovered a lump in her right breast during a routine self-examination.

Commenting on the study, Lady Morgan said: “This study was conducted in the US which has a very different healthcare system than the UK, where data on why mastectomies take place is not broken down in this way.

“Whether a woman in the UK is advised to have a double mastectomy when they are diagnosed with breast cancer in one breast will depend on the individual case, such as whether they have a family history of the disease.

“Women who are concerned about getting breast cancer in their other breast should speak to their healthcare team who will be able to provide them with support and information about the risks of this occurring and their individual treatment options.

“More research is needed into what triggers the growth of breast tumours and makes the disease progress for each patient. We hope that with more research by 2025 better and more personalised treatment options will become available for women with breast cancer, giving them the best possible chances for survival.”